{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:48:10Z","timestamp":1715593690724},"reference-count":25,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,1,31]],"date-time":"2007-01-31T00:00:00Z","timestamp":1170201600000},"content-version":"vor","delay-in-days":61,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p> <jats:italic>This national study examines the impact of the Antihypertensive and Lipid\u2010Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on the prescribing of thiazide\u2010type diuretics and other antihypertensive medications for patients with newly diagnosed hypertension. A cross\u2010sectional analysis was conducted using data from a national network of electronic health records for 2 groups with newly diagnosed hypertension and started on antihypertensive medications: one a year before and the other a year after the publication of ALLHAT. The percentage of new hypertensives started on thiazides increased from 29% pre\u2010ALLHAT to 39% post\u2010ALLHAT. An increase was also seen for angiotensin receptor blockers, while prescribing for angiotensin\u2010converting enzyme inhibitors, calcium channel blockers, and \u03b2\u2010blockers declined. There was no significant change in prescriptions for \u03b1\u2010blockers. Prescriptions for thiazides for patients with newly diagnosed hypertension increased after the publication of ALLHAT. Data from large national trials can have a considerable impact on prescribing practices.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1524-6175.2006.05781.x","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T20:46:04Z","timestamp":1170449164000},"page":"860-864","source":"Crossref","is-referenced-by-count":11,"title":["Antihypertensive Prescribing Practices: Impact of the Antihypertensive and Lipid\u2010Lowering Treatment to Prevent Heart Attack Trial"],"prefix":"10.1111","volume":"8","author":[{"given":"Marty S.","family":"Player","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather Bittner","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Arch G.","family":"Mainous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,31]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1","article-title":"National Ambulatory Medical Care Survey: 2000 summary","volume":"328","author":"Cherry DK","year":"2002","journal-title":"Adv Data"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.13.5_Suppl.I36"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199608000-00001"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91908-S"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540330061036"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03307-9"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2534"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715110-00019"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)10327-1"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02527-7"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.153.2.149"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-000-0007-1"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.15.2281"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2000.91020.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.22.1813"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing","volume":"278","author":"Siegel D","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.11.004"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.1.54"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.8.5.426"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1062860605283883"},{"key":"e_1_2_7_26_2","first-page":"349","article-title":"Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study","volume":"38","author":"Gill JM","year":"2006","journal-title":"Fam Med"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2006.05781.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2006.05781.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T21:31:19Z","timestamp":1696973479000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2006.05781.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1524-6175.2006.05781.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2006.05781.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}